Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/19/2012WO2012094834A1 Compound traditional chinese medicine extract for prevention and treatment of glycometabolism disorders and preparation method thereof
07/19/2012WO2012094833A1 Petroleum ether extract of traditional chinese medicine for prevention and treatment of sugar and lipid metabolism disorders and preparation method thereof
07/19/2012WO2012094832A1 Compound chinese medicine extract used for preventing and treating arteriosclerosis and preparation method thereof
07/19/2012WO2012094831A1 Compound traditional chinese medicine extract for prevention and treatment of lipid metabolism disorders and preparation method thereof
07/19/2012WO2012094788A1 Paraterphenyl derivative and use thereof for preparing antitumor medicaments
07/19/2012WO2012094703A1 Combination therapy
07/19/2012WO2012080982A9 Functional food preparation and use thereof
07/19/2012WO2012075319A3 Pharmaceutical cream compositions comprising oxymetazoline
07/19/2012WO2012074231A3 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
07/19/2012WO2012070068A3 Process for preparation of triclabendazole
07/19/2012WO2012069658A3 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
07/19/2012WO2012068998A3 Triamcinolone acetonide ophthalmic preparation and preparation method thereof
07/19/2012WO2012068553A3 Methods of diagnosing and treating neurodegenerative diseases
07/19/2012WO2012068549A3 Therapeutic agent formulations for implanted devices
07/19/2012WO2012067641A3 Methods and compositions for preventing and treating osteoarthritis
07/19/2012WO2012066578A3 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
07/19/2012WO2012065958A9 Method of treating contrast-induced nephropathy
07/19/2012WO2012064808A8 Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses
07/19/2012WO2012064303A3 Improved montelukast combinations
07/19/2012WO2012064302A3 Improved montelukast formulations
07/19/2012WO2012064301A3 Physically improved tablet formulations
07/19/2012WO2012064159A3 Anticancer composition
07/19/2012WO2012064130A3 Colon-targeted celecoxib precursor compound and pharmaceutical composition containing the compound as an active ingredient for treating or preventing colonic diseases
07/19/2012WO2012064088A3 Pharmaceutical composition including polymer microsphere containing olanzapine as active ingredient
07/19/2012WO2012064087A3 Pharmaceutical composition including polymer microsphere containing anastrozole as active ingredient
07/19/2012WO2012064072A3 Composition for preventing or treating rheumatoid arthritis comprising a phospholipase d1 inhibitor as an active ingredient
07/19/2012WO2012063498A3 Novel exemestane solid dispersion
07/19/2012WO2012061502A3 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
07/19/2012WO2012058529A3 Metalloenzyme inhibitor compounds
07/19/2012WO2012058492A3 Viral vaccine and process for preparing the same
07/19/2012WO2012054566A3 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
07/19/2012WO2012054521A3 Antimicrobial polyether and polyol compounds
07/19/2012WO2012051492A3 Compounds and methods for inhibiting hiv latency
07/19/2012WO2012050884A3 Cardiac glycosides are potent inhibitors of interferon-beta gene expression
07/19/2012WO2012050623A3 Novel phenoxyisobutyric acid compounds and methods for synthesis
07/19/2012WO2012048330A3 Treatment of motor neuron disease
07/19/2012WO2012048164A3 Porphyrin treatment of neurodegenerative diseases
07/19/2012WO2012047826A9 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
07/19/2012WO2012047287A9 Upregulation of opioid receptors for pain management
07/19/2012WO2012045090A3 Therapeutic use of a tlr agonist and combination therapy
07/19/2012WO2012045089A3 Methods for the treatment of allergic diseases
07/19/2012WO2012044620A3 Modulation of timp1 and timp2 expression
07/19/2012WO2012040523A3 Phosphohistidine analogs
07/19/2012WO2012035489A9 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
07/19/2012WO2012034055A3 Compounds as c-met kinase inhibitors
07/19/2012WO2012033878A3 Compounds and methods for acemif inhibition and the treatment of parasites
07/19/2012WO2012031118A3 Cell permeable inhibitors of anaphase promoting complex
07/19/2012WO2012017166A3 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
07/19/2012WO2012012305A3 Combination therapy using a ruthenium complex
07/19/2012WO2012010977A3 Single daily dosage form for prevention and treatment of metabolic syndrome
07/19/2012WO2012009447A3 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF
07/19/2012WO2012007913A3 Oral administration forms for controlled release of rifampicin or other antibiotics for the treatment of bacterial infections and inflammatory diseases of the gastrointestinal tract
07/19/2012WO2012004631A3 Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (vegfr- 2 /kdr)
07/19/2012WO2011141909A3 Lipoic acid and nitroxide derivatives and uses thereof
07/19/2012WO2011133687A3 Methods and compositions for inhibition of beta2-adrenergic receptor degradation
07/19/2012WO2011084748A3 Photo-inactivated viruses and systems and methods of using the same
07/19/2012WO2011058245A8 Novel mannopyranoside derivatives with anticancer activity
07/19/2012WO2011007247A8 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof
07/19/2012US20120185954 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression
07/19/2012US20120184626 Germicidal topical compositions
07/19/2012US20120184624 Treatment of Alzheimer's Disease
07/19/2012US20120184623 Amide derivatives of valproic acid and uses thereof
07/19/2012US20120184622 Composition for the treatment of cystic fibrosis
07/19/2012US20120184621 Method for treating phytophotodermatitis
07/19/2012US20120184620 Antioxidant composition
07/19/2012US20120184619 Composition for promoting collagen production
07/19/2012US20120184617 Process for producing fingolimod salts
07/19/2012US20120184616 Methods for treating inflammation
07/19/2012US20120184615 Stabilised prostaglandin composition
07/19/2012US20120184614 N-alkylcarbonyl-amino acid ester compounds and their use for cough and pharyngitis
07/19/2012US20120184612 Compositions and Methods Relating to Carotenoids
07/19/2012US20120184611 Selenoquinone-derived active organometallic complexes, methods for synthesizing same, and uses thereof
07/19/2012US20120184610 Methods and formulations for treating ineffective or decreased esophagal motility
07/19/2012US20120184609 Vitamin c and vitamin k, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant
07/19/2012US20120184608 N alkylcarbonyl amino lactone compounds and their use
07/19/2012US20120184607 Use of piperphentonamine or salts thereof in manufacture of madicaments for prevention/treating brain diseases
07/19/2012US20120184606 Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
07/19/2012US20120184605 Methods and compositions for treating hiv-associated diarrhea
07/19/2012US20120184604 Composition for the prevention or treatment of bone diseases comprising colforsin daropate
07/19/2012US20120184603 Novel human micrornas associated with cancer
07/19/2012US20120184602 Metabolically activated recombinant viral vectors and methods for their preparation and use
07/19/2012US20120184601 Antiviral oligonucleotides
07/19/2012US20120184600 Inhibition of Glycerol-3-Phosphate Acyltransferase (GPAT) and Associated Enzymes for Treatment of Viral Infections
07/19/2012US20120184599 Use of MicroRNA for Treating Diseases Associated with a Dysfunction of the Cilia in Multiciliated Epithelial Cells
07/19/2012US20120184598 Polynucleotides for multivalent rna interference, compositions and methods of use thereof
07/19/2012US20120184597 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
07/19/2012US20120184596 Microrna inhibitors comprising locked nucleotides
07/19/2012US20120184595 Compositions and methods for silencing apolipoprotein c-iii expression
07/19/2012US20120184594 Phenylpyrrolidine compounds
07/19/2012US20120184593 Laminin-332 production stimulating composition
07/19/2012US20120184592 Alkyl indole-3-carbinol-derived antitumor agents
07/19/2012US20120184591 Methods for treating prostatitis
07/19/2012US20120184590 Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
07/19/2012US20120184587 Novel phenol derivative
07/19/2012US20120184586 Desferrithiocin polyether analogues and uses thereof
07/19/2012US20120184585 Fatty acid niacin conjugates and their uses
07/19/2012US20120184584 Methods and drug products for treating alzheimer's disease
07/19/2012US20120184583 Modulators of atp-binding cassette transporters
07/19/2012US20120184582 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
07/19/2012US20120184581 Oligomer-Opioid Agonist Conjugates
1 ... 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 ... 7860